KLTO
Klotho Neurosciences, Inc.
NASDAQ: KLTO · HEALTHCARE · BIOTECHNOLOGY
$0.52
+0.00% today
Updated 2026-04-30
Market cap
$56.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
9.5M
Klotho Neurosciences, Inc. (KLTO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| R&D | — | — | — | — | — |
| SG&A | $165.00 | $1.11M | $574374.00 | $631322.00 | $5.54M |
| Operating income | $-913147.00 | $-1.11M | $-574374.00 | $-631322.00 | $-5.54M |
| Operating margin | — | — | — | — | — |
| EBITDA | — | $-1.11M | $-574227.00 | $-631244.00 | $-5.79M |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-913147.00 | $-1.11M | $-574374.00 | $-631322.00 | $-5.54M |
| Interest expense | — | $0.00 | $24366.00 | $76214.00 | $356603.00 |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-913.00 | $-1.11M | $-598593.00 | $-707458.00 | $-6.15M |
| Net income growth (YoY) | — | -121370.4% | +46.0% | -18.2% | -769.4% |
| Profit margin | — | — | — | — | — |